A highly rifampicin resistant Mycobacterium tuberculosis strain emerging in Southern Brazil

被引:9
作者
Rossetti, Maria Lucia [1 ,4 ]
Almeida da Silva, Pedro Eduardo [2 ]
Salvato, Richard Steiner [3 ,4 ]
Reis, Ana Julia [2 ]
Schiefelbein, Sun Hee [1 ,3 ]
von Groll, Andrea [1 ]
Barcellos, Regina Bones [3 ,5 ]
Maschmann, Raquel [3 ]
Esteves, Leonardo Souza [5 ]
Spies, Fernanda [3 ]
Trespach, Rubia Raubach [1 ]
Dalla Costa, Elis Regina [5 ]
Neubauer de Amorim, Hermes Luis [6 ]
机构
[1] Univ Luterana Brasil ULBRA, Programa Posgrad Biol Celular & Mol Aplicada Saud, Canoas, RS, Brazil
[2] Univ Fed Rio Grande, Fac Med, Nucleo Pesquisa Microbiol Med NUPEMM, Rio Grande, RS, Brazil
[3] Secretaria Estadual Saude Rio Grande do Sul, Ctr Estadual Vigilancia Saude, Ctr Desenvolvimento Cient & Tecnol CDCT, Porto Alegre, RS, Brazil
[4] Univ Fed Rio Grande do Sul UFRGS, Ctr Biotecnol, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil
[5] Univ Fed Rio de Janeiro, Fac Med, Programa Posgrad Clin Med, Programa Acad TB, Rio De Janeiro, RJ, Brazil
[6] In Silico Solut LTDA, Porto Alegre, RS, Brazil
关键词
Mycobacterium tuberculosis; Resistance; Whole genome sequencing; Rifampicin; Transmission; DRUG-RESISTANCE; MULTIDRUG-RESISTANT; PROTEIN; DOCKING; MUTATIONS; ASSAY; GENE; TOOL;
D O I
10.1016/j.tube.2020.102015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Here we described phenotypical, molecular and epidemiological features of a highly rifampicin-resistant Mycobacterium tuberculosis strain emerging in Southern Brazil, that carries an uncommon insertion of 12 nucleotides at the codon 435 in the rpoB gene. Employing a whole-genome sequencing-based study on drug-resistant Mycobacterium tuberculosis strains, we identified this emergent strain in 16 (9.19%) from 174 rifampicin-resistant clinical strains, all of them belonging to LAM RD115 sublineage. Nine of these 16 strains were available to minimum inhibitory concentration determination and for all of them was found a high rifampicin-resistance level (>= to 32 mg/L). This high resistance level could be explained by structural changes into the RIF binding site of RNA polymerase caused by the insertions, and consequent low-affinity interaction with rifampicin complex confirmed through protein modeling and molecular docking simulations. Epidemiological investigation showed that most of the individuals (56.25%) infected by the studied strains were prison inmate individuals or that spent some time in prison. The phylogenomic approach revealed that strains carrying on insertion belonged to same genomic cluster, evidencing a communal transmission chain involving inmate individuals and community. We stress the importance of tuberculosis genomic surveillance and introduction of measures to interrupt Mycobacterium tuberculosis transmission chain in this region.
引用
收藏
页数:7
相关论文
共 50 条
  • [32] Mutations in the rpoB gene of rifampicin-resistant Mycobacterium tuberculosis strains isolated in Brazil and France
    de Miranda, SS
    Kritski, A
    Filliol, I
    Mabilat, C
    Panteix, G
    Drouet, E
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2001, 96 (02): : 247 - 250
  • [33] Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of Mycobacterium Tuberculosis from Iran
    Kardan-Yamchi, Jalil
    Kazemian, Hossein
    Battaglia, Simone
    Abtahi, Hamidreza
    Foroushani, Abbas Rahimi
    Hamzelou, Gholamreza
    Cirillo, Daniela Maria
    Ghodousi, Arash
    Feizabadi, Mohammad Mehdi
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)
  • [34] Trends in the incidence of Rifampicin resistant Mycobacterium tuberculosis infection in northeastern Nigeria
    Ibrahim, Muhammad M.
    Isyaka, Tom M.
    Askira, Umoru M.
    Umar, Jidda B.
    Isa, Mustafa A.
    Mustapha, Adam
    Salihu, Akbar
    SCIENTIFIC AFRICAN, 2022, 17
  • [35] Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis
    Al-Mutairi, Noura M.
    Ahmad, Suhail
    Mokaddas, Eiman
    Eldeen, Hanaa S.
    Joseph, Susan
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [36] Rifampicin-resistant Tuberculosis: A Global Health Dilemma
    Ahmad, Rahnuma
    Sinha, Susmita
    Chowdhury, Kona
    Haque, Mainul
    ADVANCES IN HUMAN BIOLOGY, 2024, 14 (02) : 87 - 91
  • [37] Genotyping and molecular characteristics of multidrug-resistant Mycobacterium tuberculosis isolates from China
    Zhang, Zhijian
    Lu, Jie
    Liu, Min
    Wang, Yufeng
    Qu, Geping
    Li, Hongxia
    Wang, Jichun
    Pang, Yu
    Liu, Changting
    Zhao, Yanlin
    JOURNAL OF INFECTION, 2015, 70 (04) : 335 - 345
  • [38] Transmission patterns of rifampicin resistant Mycobacterium tuberculosis complex strains in Cameroon: a genomic epidemiological study
    Merker, Matthias
    Egbe, Nkongho F.
    Ngangue, Yannick R.
    Vuchas, Comfort
    Kohl, Thomas A.
    Dreyer, Viola
    Kuaban, Christopher
    Noeske, Jurgen
    Niemann, Stefan
    Sander, Melissa S.
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [39] Pharmacophore insights into rpoB gene mutations in Mycobacterium tuberculosis rifampicin resistant isolates
    Figueiredo, Ricardo
    Ramos, Daniela F.
    Moiteiro, Cristina
    Medeiros, Maria Augusta
    Marcelo Curto, Maria Joao
    de Menezes, Jose Cardoso
    Hernandez Pando, Rogelio
    Silva, Pedro E. A.
    Costa, Maria do Ceu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 47 : 186 - 193
  • [40] In Vitro Activity of Rifampicin and Verapamil Combination in Multidrug-Resistant Mycobacterium tuberculosis
    Demitto, Fernanda de Oliveira
    Ribeiro do Amaral, Renata Claro
    Maltempe, Flaviane Granero
    Dias Siqueira, Vera Lucia
    de Lima Scodro, Regiane Bertin
    Lopes, Mariana Aparecida
    Caleffi-Ferracioli, Katiany R.
    Canezin, Pedro Henrique
    Cardoso, Rosilene Fressatti
    PLOS ONE, 2015, 10 (02):